These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 10800158)

  • 21. Chronic granulomatous disease: towards gene therapy.
    Thrasher A; Segal A; Casimir C
    Immunodeficiency; 1993; 4(1-4):327-33. PubMed ID: 8167728
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Superoxide auto-augments superoxide formation and upregulates gp91(phox) expression in porcine pulmonary artery endothelial cells: inhibition by iloprost.
    Muzaffar S; Shukla N; Angelini GD; Jeremy JY
    Eur J Pharmacol; 2006 May; 538(1-3):108-14. PubMed ID: 16647052
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular analysis of chronic granulomatous disease caused by defects in gp91-phox.
    Patiño PJ; Perez JE; Lopez JA; Condino-Neto A; Grumach AS; Botero JH; Curnutte JT; García de Olarte D
    Hum Mutat; 1999; 13(1):29-37. PubMed ID: 9888386
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term correction of phagocyte NADPH oxidase activity by retroviral-mediated gene transfer in murine X-linked chronic granulomatous disease.
    Dinauer MC; Li LL; Björgvinsdóttir H; Ding C; Pech N
    Blood; 1999 Aug; 94(3):914-22. PubMed ID: 10419882
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression and characterization of the flavoprotein domain of gp91phox.
    Han CH; Lee MH
    J Vet Sci; 2000 Jun; 1(1):19-26. PubMed ID: 14612616
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induction of gp91-phox, a component of the phagocyte NADPH oxidase, in microglial cells during central nervous system inflammation.
    Green SP; Cairns B; Rae J; Errett-Baroncini C; Hongo JA; Erickson RW; Curnutte JT
    J Cereb Blood Flow Metab; 2001 Apr; 21(4):374-84. PubMed ID: 11323523
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Construction of a high efficiency retroviral vector for gene therapy of Hunter's syndrome.
    Hong Y; Yu SS; Kim JM; Lee K; Na YS; Whitley CB; Sugimoto Y; Kim S
    J Gene Med; 2003 Jan; 5(1):18-29. PubMed ID: 12516048
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Generation of a conditionally neo(r)-containing retroviral producer cell line: effects of neo(r) on retroviral titer and transgene expression.
    Wildner O; Candotti F; Krecko EG; Xanthopoulos KG; Ramsey WJ; Blaese RM
    Gene Ther; 1998 May; 5(5):684-91. PubMed ID: 9797874
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Left ventricular remodeling after myocardial infarction in mice with targeted deletion of the NADPH oxidase subunit gp91PHOX.
    Frantz S; Brandes RP; Hu K; Rammelt K; Wolf J; Scheuermann H; Ertl G; Bauersachs J
    Basic Res Cardiol; 2006 Mar; 101(2):127-32. PubMed ID: 16273323
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of five retrovirus vectors containing the human IL-2 receptor gamma chain gene for their ability to restore T and B lymphocytes in the X-linked severe combined immunodeficiency mouse model.
    Avilés Mendoza GJ; Seidel NE; Otsu M; Anderson SM; Simon-Stoos K; Herrera A; Hoogstraten-Miller S; Malech HL; Candotti F; Puck JM; Bodine DM
    Mol Ther; 2001 Apr; 3(4):565-73. PubMed ID: 11319919
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Liposome-mediated cellular delivery of active gp91(phox).
    Marques B; Liguori L; Paclet MH; Villegas-Mendéz A; Rothe R; Morel F; Lenormand JL
    PLoS One; 2007 Sep; 2(9):e856. PubMed ID: 17848987
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hereditary deficiency of gp91(phox) is associated with enhanced arterial dilatation: results of a multicenter study.
    Violi F; Sanguigni V; Carnevale R; Plebani A; Rossi P; Finocchi A; Pignata C; De Mattia D; Martire B; Pietrogrande MC; Martino S; Gambineri E; Soresina AR; Pignatelli P; Martino F; Basili S; Loffredo L
    Circulation; 2009 Oct; 120(16):1616-22. PubMed ID: 19805647
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A retroviral packaging cell line for pseudotype vectors based on glioma-infiltrating progenitor cells.
    Fischer YH; Miletic H; Giroglou T; Litwak S; Stenzel W; Neumann H; von Laer D
    J Gene Med; 2007 May; 9(5):335-44. PubMed ID: 17474071
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of transient expression system for retroviral vector production.
    Hotta A; Saito Y; Kyogoku K; Kawabe Y; Nishijima K; Kamihira M; Iijima S
    J Biosci Bioeng; 2006 Apr; 101(4):361-8. PubMed ID: 16716946
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of methotrexate resistance conferred by a mutated dihydrofolate reductase (DHFR) cDNA in two different retroviral vectors.
    Takebe N; Nakahara S; Zhao SC; Adhikari D; Ural AU; Iwamoto M; Banerjee D; Bertino JR
    Cancer Gene Ther; 2000 Jun; 7(6):910-9. PubMed ID: 10880023
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A donor splice site mutation in intron 1 of CYBA, leading to chronic granulomatous disease.
    de Boer M; Hartl D; Wintergerst U; Belohradsky BH; Roos D
    Blood Cells Mol Dis; 2005; 35(3):365-9. PubMed ID: 16157492
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Superoxide production and NADPH oxidase expression in human rheumatoid synovial cells: regulation by interleukin-1beta and tumour necrosis factor-alpha.
    Chenevier-Gobeaux C; Lemarechal H; Bonnefont-Rousselot D; Poiraudeau S; Ekindjian OG; Borderie D
    Inflamm Res; 2006 Nov; 55(11):483-90. PubMed ID: 17122966
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of splice-site mutations of the human MDR1 cDNA on its stability and expression following retroviral gene transfer.
    Cmejlova J; Hildinger M; Cmejla R; Fuchs O; Kalabova D; Baum C; Jelinek J
    Gene Ther; 2003 Jun; 10(12):1061-5. PubMed ID: 12776165
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Retroviral end-point titer is not predictive of gene transfer efficiency: implications for vector production.
    Forestell SP; Böhnlein E; Rigg RJ
    Gene Ther; 1995 Dec; 2(10):723-30. PubMed ID: 8750011
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The selectable marker neo gene down-regulates gene expression from retroviral vectors containing an internal ribosome entry site.
    Byun J; Kim JM; Robbins PD; Kim S
    Gene Ther; 1998 Oct; 5(10):1441-4. PubMed ID: 9930351
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.